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Fibroblasts at the wound site are recognized as the 
primary drivers of scar formation. They differentiate 
into myofibroblasts, the key mediators of fibrosis, 
which are responsible for collagen deposition and 
wound contraction. Repair processes cease when 
epithelialization is completed in normal wounds, 
whereas in keloid wounds, they may continue and 
result in excessive accumulation of unorganized 
extracellular matrix, forming problematic scars.
In addition to resident mesenchymal cells, 
fibroblasts and myofibroblasts are thought to be 
derived from multiple sources, including  epithelial-
mesenchymal transition (EMT) [1]. During this 
process, epithelial cells experience intercellular and 
intracellular changes, including dissociation of 
junctional complexes, loss of apical-basolateral 
polarity, and repression of epithelial markers. As a 
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Fig. 1. 
Patient with a keloid. A 
70-year-old male with a 
keloid on the post-sternotomy 
area suffered from itchiness, 
pain, and skin tightening. The 
keloid was surgically excised 
intralesionally.
Fig. 2.  
Epithelial-mesenchymal transition (EMT) characteristics 
in keloid tissue. (A) Expression of the epithelial marker 
E-cadherin (green) and (B) the mesenchymal marker 
vimentin (red) was observed via immunofluorescence. 
(C) DAPI counterstain of nuclei (blue). (D) Co-expression 
of E-cadherin and vimentin at the dermo-epidermal 
junction was observed, indicating the occurrence of the 
EMT process (A-D, magnification ×630). 
result, epithelial cells lose many of their properties 
and take on characteristics of mesenchymal cells. 
To investigate this process, an immunofluorescence 
assay using both epithelial and mesenchymal markers 
was performed using keloid tissues obtained from the 
anterior chest wall of a 70-year-old male patient (Fig. 
1). After fixation, cells were incubated with primary 
antibodies against E-cadherin and vimentin (Abcam, 
Cambridge, UK), and subsequently labelled with 
fluorescently-tagged secondary antibodies. 
Counterstaining with 4’,6-diamidino-2-phenylindole 
(DAPI) (VECTOR Laboratories, Burlingame, CA, 
USA) was also performed. 
Cells were visualized using an LSM 700 Carl Zeiss 
confocal microscope (Carl Zeiss MicroImaging, 
Thornwood, NY, USA). E-cadherin and vimentin 
expression were simultaneously observed at the 
dermo-epidermal junction in keloid tissue, indicating 
the occurrence of EMT (Fig. 2).
Although further investigations with additional 
keloid specimens are needed, we hope that our study 
yields some insight into the mechanisms of keloid 
formation.
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Recently, many studies have shown no difference in 
efficacy between musculocutaneous and 
fasciocutaneous flaps in the treatment of 
osteomyelitis [1]. The aim of this study was to 
examine the efficacy of the reverse sural 
fasciocutaneous flap for the reconstruction of chronic 
osteomyelitis defects on the distal lower leg. Between 
March 2013 and March 2018, five adult patients aged 
38 to 85 years who underwent reconstruction with a 
reverse sural fasciocutaneous flap were included in 
this study (Table 1). These patients were diagnosed 
with chronic osteomyelitis at the Department of 
Orthopedic Surgery of Myongji Hospital and were 
referred to the Department of Plastic and 
Reconstructive Surgery for reconstruction of the soft 
tissue defects. Delayed distally-based fasciocutaneous 
reverse sural flaps were used in a 2-step procedure 
[2]. The patients were followed in our outpatient 
clinic and their healing status was quantitatively 
compared with previous findings by 3-phase bone 
scans, which all patients agreed to have performed for 
postoperative follow-up. Four of the five patients 
recovered progressively from osteomyelitis without 
complications, such as necrosis of the distal aspect of 
the flap or marginal dehiscence. These patients 
showed clinical resolution at the time of the last 
Patient 
no.
Age (yr)/ 
sex
Diagnosis Risk factors
Delay 
period 
(day)
Size of the 
flap (cm2)
Complications
Duration of 
follow-up 
(mo)
1 68/male Chronic osteomyelitis on the lateral 
malleolus caused by abscess 
formation
None 11 9×3 None 6 
2 38/male Chronic osteomyelitis on the 
calcaneus caused by surgical site 
infection
Smoker 10 14.5×4 None 7 
3 62/male Chronic osteomyelitis on the first 
metatarsal bone caused by 
diabetic foot
Diabetes mellitus, 
smoker
14 5×4 None 18
4 85/male Chronic osteomyelitis on the tibia 
caused by an open tibiofibular 
fracture
Old cerebral infarction, 
peripheral arterial 
occlusive disease
15 12.5×5 None 6 
5 65/male Chronic osteomyelitis on the 
calcaneus caused by diabetic 
foot
Diabetes mellitus 14 15×6.5 Bone necrosis 12
Table 1. Demographics and clinical characteristics of the patients
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